Dr. Hakanson, an anesthesiologist, has more than 16 years of experience in medical affairs, market access and health economic research. He most recently served as the vice president and head of health economics & outcomes research for U.S. medical and drug regulatory affairs at Novartis. He has also previously worked as vice president of healthcare access at Bristol-Myers Squibb.
Dr. Hakanson is a diplomat of the American Board of Anesthesiology and American Society of Anesthesiologists.
Otonomy is a clinical-stage biopharmaceutical company focusing on the development and commercialization of therapies for diseases and disorders of the ear.
More articles on anesthesia:
Annual & hourly anesthesiologist pay: 8 statistics
Somnia Anesthesia calls for anesthesiologist of the year award nominations
Dr. Julian Gold named mayor of California’s Beverly Hills
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
